For none priority patients, it is probably taking a longer turn around time since the current testing capacity is not enough. I remember Bio reference said they prioritize hospital test requests for now. You can check the national total of reference lab testing power https://www.acla.com/covid-19/ I believe Bio reference is doing around 20k per day before they receive any support from the federal government. However, as you said before, the testing revenue would not make a big difference to their income sheet. I am more interesting to the phase 3 result right now.
Market Data 
Markets 
AI
